Ro4938581 is usually a nootropic drug invented in 2009 by a group Doing the job for Hoffmann-La Roche, which functions to be a subtype-selective inverse agonist for the α5 subtype in the benzodiazepine binding website within the GABAA receptor. It has excellent selectivity to the α5 subt